Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2007-8-16
pubmed:abstractText
Advanced pancreatic cancer has a poor prognosis. Gemcitabine (GEM) can improve the quality of life of pancreatic cancer patients. However, the efficacy of gemcitabine-based combination chemotherapy is uncertain. This study was to compare the efficacy of GEM-based combination therapy and GEM alone on advanced pancreatic cancer.
pubmed:language
chi
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1000-467X
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
890-4
pubmed:meshHeading
pubmed-meshheading:17697554-Adenocarcinoma, pubmed-meshheading:17697554-Aged, pubmed-meshheading:17697554-Anemia, pubmed-meshheading:17697554-Antimetabolites, Antineoplastic, pubmed-meshheading:17697554-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:17697554-Cisplatin, pubmed-meshheading:17697554-Deoxycytidine, pubmed-meshheading:17697554-Female, pubmed-meshheading:17697554-Fluorouracil, pubmed-meshheading:17697554-Follow-Up Studies, pubmed-meshheading:17697554-Humans, pubmed-meshheading:17697554-Leukopenia, pubmed-meshheading:17697554-Male, pubmed-meshheading:17697554-Middle Aged, pubmed-meshheading:17697554-Neoplasm Staging, pubmed-meshheading:17697554-Organoplatinum Compounds, pubmed-meshheading:17697554-Pancreatic Neoplasms, pubmed-meshheading:17697554-Remission Induction, pubmed-meshheading:17697554-Survival Rate
pubmed:year
2007
pubmed:articleTitle
[Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
pubmed:affiliation
Department of Digestive Disease, School of Oncology & Beijing Cancer Hospital, Peking University, Beijing, 100036, PR China.
pubmed:publicationType
Journal Article, English Abstract